Indication

Refractory Follicular Helper T-Cell Lymphoma

1 clinical trial

1 product

Clinical trial

A Phase I Trial of MEDI-570 in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) Follicular Variant and Angioimmunoblastic T-Cell Lymphoma (AITL)

Status: Active (not recruiting), Estimated PCD: 2023-08-04

Product